Vitrolife AB: Interim report Q2, 2025: Strong performance across Consumables
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 17 2025
0mins
Source: Yahoo Finance
Financial Performance: Vitrolife AB reported flat sales growth in local currencies for Q2 2025, with a total of SEK 871 million, but a 7% decrease in SEK due to currency impacts. The company experienced organic growth of 3% excluding discontinued business, while gross margin decreased to 58.0%.
Regional and Product Group Sales: Sales varied by region, showing a decline in EMEA and APAC, while the Americas saw a 5% increase. In product groups, Consumables grew by 9%, Technologies declined by 6%, and Genetics had a slight increase of 3%.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
